Idiopathische CD4+-T-lymfocytopenie

Contains fulltext : 4895.pdf (publisher's version ) (Open Access

Revisie van de richtlijn 'Dyspneu in de palliatieve fase'

The guideline ‘Dyspnea in the palliative phase’ was revised in 2015. The members of the working group were mandated by several scientific, professional and patient organisations. On the basis of a bottleneck analysis several scientific questions were formulated. The questions about non-pharmacological and pharmacological symptomatic treatment of dyspnea were analysed evidence-based. In this paper a short summary is given of the most important conclusions and recommendations of the guideline

Revisie van de richtlijn 'Dyspneu in de palliatieve fase'

The guideline ‘Dyspnea in the palliative phase’ was revised in 2015. The members of the working group were mandated by several scientific, professional and patient organisations. On the basis of a bottleneck analysis several scientific questions were formulated. The questions about non-pharmacological and pharmacological symptomatic treatment of dyspnea were analysed evidence-based. In this paper a short summary is given of the most important conclusions and recommendations of the guideline

A delay in CD4 cell response after initiation of highly active antiretroviral therapy is associated with the presence of anti-cytomegalovirus but not with anti-herpes simplex virus antibodies.

Item does not contain fulltextAfter the successful initiation of highly active antiretroviral therapy (HAART) in HIV-1-infected patients, the mean CD4 cell response was lower in cytomegalovirus (CMV)-seropositive patients than in CMV-seronegative patients (P < 0.05). The difference between the mean CD4 cell counts of CMV-seronegative and CMV-seropositive patients was maximal (163 x 10(6)/l) at 76 weeks after the start of HAART, and decreased gradually thereafter. No association was found between herpes simplex virus types 1 and 2 serostatus and CD4 cell response

A delay in CD4 cell response after initiation of highly active antiretroviral therapy is associated with the presence of anti-cytomegalovirus but not with anti-herpes simplex virus antibodies.

Item does not contain fulltextAfter the successful initiation of highly active antiretroviral therapy (HAART) in HIV-1-infected patients, the mean CD4 cell response was lower in cytomegalovirus (CMV)-seropositive patients than in CMV-seronegative patients (P < 0.05). The difference between the mean CD4 cell counts of CMV-seronegative and CMV-seropositive patients was maximal (163 x 10(6)/l) at 76 weeks after the start of HAART, and decreased gradually thereafter. No association was found between herpes simplex virus types 1 and 2 serostatus and CD4 cell response

Evaluation of the effectiveness of four different inhalers in patients with chronic obstructive pulmonary disease.

Item does not contain fulltex